The treatment is the comprehensive care surrounding it." GLP-1 medications are transforming obesity and cardio-kidney-metabolic carebut they should be prescribed within a comprehensive clinical model that includes: Thorough medical evaluation Personalized treatment planning Ongoing medication management Nutrition, behavioral, and lifestyle support Longitudinal follow-up to optimize outcomes Read the JAMA study: #ObesityMedicine #GLP1 #CardiometabolicHealth #Telehealth #DigitalHealth #eCKM #CKM #FlyteHealth To view or add a comment, sign in Great perspective from Katherine Saunders, MD, FTOS As GLP-1 access continues to grow, its important to remember that the medication is only one piece of the puzzle
Pediatr Radiol 42(6):699705 Qingqing R, Hongxu C, Yuelong W, Jianguo X (2019) Melanotic neuroectodermal tumor of infancy arising in the skull and brain: a systematic review
As a Nutritionist, Im continuing my mission to help women like you, beat PCOS
No subject was withdrawn from a clinical trial due to an adverse reaction
The surgeons technical skills and technique
Now applied to GLP-1 care
